| 1 |
31375570 | The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer. | 2020 Feb |
2 |
| 2 |
30256977 | Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers. | 2019 May 1 |
1 |
| 3 |
30337961 | Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells. | 2018 |
2 |
| 4 |
19152441 | High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. | 2009 Mar 1 |
2 |
| 5 |
19861538 | The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. | 2009 Nov 1 |
1 |
| 6 |
17317846 | Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant. | 2007 Feb 15 |
2 |